Scientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithelial ovarian cancer risk of between 5% and 20% has a much higher than expected detection rate. Routine testing for mutations in homologous recombination (HR) and mismatch repair (MMR) genes in women ...
View more: Gene mutations should be tested routinely for ovarian cancer, say scientists